Global Health and DLF Group to develop 400-bed multi-specialty hospital in Delhi

Global Health (MEDANTA), India’s leading private multi-specialty tertiary care provider and DLF Group (DLF), India’s leading real estate developer have entered into an understanding for forming a company to launch around 400-bed multi-super specialty hospital to provide the highest quality of healthcare in the heart of Delhi in Greater Kailash -I. Both Medanta and DLF will own 50-50 equity in the new company. DLF will be a strategic investor and Medanta will run the hospital and have operational control.

The super specialty hospital is slated to provide cutting-edge medical and surgical interventions in over 20 super specialties, including Cardiac sciences, Neurosciences, Orthopaedics, Kidney, Liver, Lung and Heart Transplants, Gastroenterology and Chest Surgery. The facility will also have a Comprehensive Cancer Care unit, offering end-to-end oncology treatments under one roof.

This new facility will strengthen Medanta’s presence in the National Capital Region of Delhi. Medanta will operate its Gurugram, Noida and Delhi facilities in a seamless manner linking its existing 1,391-bed flagship hospital in Gurugram and its upcoming Noida facility (550 beds) to the new hospital in South Delhi.

Global Health is one of the largest multi-specialty tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues committed to its core mission of delivering advanced and affordable healthcare services to patients supported by technology and research.

Today, the stock opened at Rs 706, with a high and low of Rs 709.65 and Rs 672.45. The stock is currently trading at Rs 682.00, down by 1.04%. The stock has a 52-week high of Rs 728.50 and a 52-week low of Rs 391.05. The company has a ROCE of 16.8% and an ROE of 16.1% with a market capitalisation of Rs 18,277 crore. 

In the last six months, the shares of the company have given about 45% returns, and investors should keep a close eye on this stock.